Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Use and Abuse of HOMA Modeling
2004 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
1993
Pathogenesis of type 2 diabetes mellitus
2004
ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy
2013 StandoutNobel
Quantitative study of insulin secretion and clearance in normal and obese subjects.
1988
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Interactions Between Glucose and FFA Metabolism in Man
1996
Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
1998
Cushing's syndrome
2015 Standout
Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma
2002
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery
2002
Pituitary Adenomas with Invasion of the Cavernous Sinus Space
1993 Standout
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
1999
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Relationship Between Admission Hyperglycemia and Neurologic Outcome of Severely Brain-Injured Patients
1989
Diabetic ketoacidosis in children and adolescents with diabetes
2009
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Cellular mechanisms of insulin resistance
2000 Standout
von Hippel-Lindau disease
2003 Standout
Disordered metabolism in diabetes: Have we underemphasized the fat component?
1994
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Erythrocyte‐Inspired Delivery Systems
2012
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
2004
Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation
2008
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Biological Gene Delivery Vehicles: Beyond Viral Vectors
2009
Type 1 diabetes
2013 Standout
Fatty acids, lipotoxicity and insulin secretion
1999
Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro
2008
The Physiology of Glucagon-like Peptide 1
2007 Standout
Pharmacokinetics of Oxicam Nonsteroidal Anti-Inflammatory Agents
1994
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
The ChEMBL database in 2017
2016 Standout
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis
1997 StandoutNobel
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
2004
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
2011 Standout
Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome
2009
An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
1995 Standout
Treatment of Traumatic Brain Injury with Moderate Hypothermia
1997 Standout
Metabolic and molecular basis of insulin resistance
2003
Prediabetes: a high-risk state for diabetes development
2012 Standout
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
1993 Standout
Roles of PPARs in health and disease
2000 StandoutNature
Etomoxir: a new approach to treatment of chronic heart failure
2000
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
2008 StandoutNobel
Adipose Tissue as an Endocrine Organ
2004 Standout
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
2004
Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.
1995
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study
1983 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation
2012
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Decreased hepatic insulin extraction in subjects with mild glucose intolerance
1983
European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents
2004
Impact of Glucose Ingestion on Hepatic and Peripheral Glucose Metabolism in Man: An Analysis Based on Simultaneous Use of the Forearm and Double Isotope Techniques*
1986
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
2004
Carnitine Palmitoyltransferase (CPT) Modulators: A Medicinal Chemistry Perspective on 35 Years of Research
2011
Diabetic Cardiomyopathy
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes
1986
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Incretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*
1986
Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM
1991
Regulation of hepatic glucose metabolism in humans
1987
Assessment of Insulin Sensitivityin Vivo*
1985
Unconventional Methods for Fabricating and Patterning Nanostructures
1999 Standout
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Diabetic ketoacidosis and hyperglycemic hyperosmolar state
2014
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
1986
Interactions Between Glucose and FFA Metabolism in Man
1996
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
2007
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
The Metabolic Syndrome
2008 Standout
THE HALF‐LIFE OF ENDOGENOUS INSULIN AND C‐PEPTIDE IN MAN ASSESSED BY SOMATOSTATIN SUPPRESSION
1985
A double-blind, randomized trial of PY108-068 in acute ischemic cerebral infarction.
1989
Ventricular fluid interleukin-1 activity in patients with head injury.
1987
Clinical trials of homoeopathy.
1991
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes
2004
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
2000
Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans
1988
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
2003 Standout
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
1992 Science
Works of A. Korn being referenced
[Controlled randomized double-blind study for the comparison of the treatment of patients with essential hypertension with homeopathic and with pharmacologically effective drugs].
1982
Plasma concentrations of free and sulfoconjugated dopamine, epinephrine, and norepinephrine in healthy infants and children
1989
DOSE LINEARITY ASSESSMENT OF GLIMEPIRIDE (AMARYL®) TABLETS IN HEALTHY VOLUNTEERS
1994
Proliferation in Pituitary Adenomas: Measurement by MAb KI 67
1991
Pharmacokinetics and Pharmacodynamics of the Hydroxy-Metabolite of Glimepiride (Amaryl®) After Intravenous Administration
1996
Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus
1991
ABSOLUTE BIOAVAILABILITY OF GLIMEPIRIDE (AMARYL®) AFTER ORAL ADMINISTRATION
1994
Survival of gentamicin‐loaded carrier erythrocytes in healthy human volunteers
1986
Urinary catecholamine excretion and thyroid hormone blood level in the course of severe acute brain damage
1975
Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man
1979
Effect of buformin on splanchnic carbohydrate and substrate metabolism in healthy man
1981
Severe Hyperglycemia: Effects of Rehydration on Endocrine Derangements and Blood Glucose Concentration
1979
Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man.
1993
Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus
1982
Intracranial effects of nicardipine.
1985
In vivo clearance of antibody-sensitized human drug carrier erythrocytes
1986
Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.
1990